Getinib (Gefitinib) 250 MG – 30 TABLETS


Getinib is used as the initial treatment for patients who have advanced non-small cell lung cancer (NSCLC) that has spread, and whose tumors contain specific mutations in the epidermal growth factor receptor (EGFR). These mutations are identified through an FDA-approved test and include exon 19 deletions or exon 21 (L858R) substitution mutations.

Whatsapp +8801922101029